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ABSTRACT 
Rats previously exposed to caffeine during both gestation and 
lactation at a low and high dose and saline-treated animals were given five 
drugs intraperitoneally in successive weeks. Rats were divided into two 
equal groups, the first receiving saline, diazepam (a benzodiazepine) at low 
and high dose and caffeine at low and high dose. The second group were 
given saline, Chlorohexyladenosine (CHA, an adenosine agonist) and 
oxprenolol (a beta-blocker). After drug administration each rat was tested in 
an open field and emergence apparatus. 
Greater activity was found with caffeine doses, but lower activity and 
more grooming in the high perinatal caffeine group. Sedation was the main 
effect with diazepam at high doses and CHA at both doses, while oxprenolol 
had a slight stimulatory effect on activity. Increased centre occupancy was 
found with all three of these drugs in the high perinatal caffeine group but 
only in the CHA group did this interact with the high dose given. 
None of the drugs had a marked effect on behaviour of rats but the 
implication is that anti-anxiety effects may have occurred for all three drugs 
but was more marked with CHA. This supports a role for adenosine in 
caffeine's effects on behaviour. 
This is in agreement with research suggesting that adenosine is 
responsible for caffeine's anxiogenic role, and research showing an 
upregulation of adenosine receptors after chronic caffeine exposure. This 
finding is tentative, more work is required to discover the mechanisms 




The common use and general acceptance of coffee in today's society 
has led to a situation where caffeine has become a potential drug of abuse. 
Its stimulant properties have led to an overuse as people rely on it to keep 
them awake and alert. A high percentage of the population drink tea or 
coffee and those who do not may be exposed to caffeine in soft drinks or 
chocolate and other cocoa products, its use in many products such as 
medicines has made it possible for people to be unaware of the amount of 
caffeine they are consuming. Because it is readily available and consumed by 
a large number of people worldwide, it is considered harmless and therefore 
most people do not concern themselves with the possible negative effects 
from drinking it in large quantities or while pregnant and/ or breast-feeding. 
However, increasing concern about this particular issue has 
developed and is the concern of this thesis. I would like to give a brief 
description of caffeine and the effect it has as a stimulant as well as the 
effects with higher chronic consumption. Caffeine has a number of effects 
on the body which, at low doses may not be particularly harmful but with a 
high dose, can be fully expressed in a detrimental way. This can lead to 
problems which may result in one being diagnosed with psychiatric 
disorders and prescribed drugs to combat a condition which is reversible 
simply by reducing the amount of caffeine that is being consumed. 
These physiological and psychological effects of caffeine will be 
explored. Of great interest is caffeine's teratogenic potential, both 
behaviourally and physically, which may be long-lasting. This will be 
examined in humans, for whom research is limited due to the ethics and 
retrospective problems which exist, and in animal research which will help 
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to understand the effects that caffeine has when it acts on the foetus and 
lactating animals. An examination of the theories for caffeine's actions ,,vill 
then be undertaken with a presentation of the research carried out in this 
area. Some hypotheses that emerge from the research will be proposed 
leading to the rationale for my study. 
CAFFEINE'S PHYSIOLOGICAL EFFECTS 
Caffeine is a xanthine, known as 1,3,7 trimethylxanthine. It is a 
central nervous system (CNS) stimulant along with theobromine which is 
also in the xanthine family. Caffeine is contained in a number of items 
such as the obvious coffee and tea but also in Coca cola, chocolate bars, 
cocoa and in medications such as Nodoz and Anacin. The amount of 
caffeine in each of the beverages varies greatly (Table one). A 5 oz cup of 
brewed coffee can contain between 40 and 180 milligrams (mg) of caffeine 
while a cup of instant coffee can contain between 30 and 120 mg 
(Sobotka,1989). 
This wide variability can make the calculation of caffeine intake 
difficult to assess, particularly when relying on a person's self report, 
therefore studies assessing effects on ·subjects after specified doses are 
provided are more reliable. 
Stimulant effects occur at doses of around 2 - 4 mg/kg which is about 
one or two cups of coffee for most people. At doses higher than 5 mg/kg 
adverse effects to caffeine develop and withdrawal is usually experienced 
when chronic consumption of this amount occurs (Weiss and Laties, 1962). 
When caffeine ingestion reaches greater than 1000 mg, caffeinism occurs. 
However, lethal doses are very high, over 15 grams which is far higher than 
would normally be ingested. 
Table 1: Caffeine content of common commodities 
Product Average mg. caffeine 
Coffee - brewed 98 
-instant 65 
Tea - brewed 
- instant/iced 
Cocoa beverage (5 oz) 
Chocolate (1 oz) 
Soft drink (12 oz) 
Prescription drugs 
Weight control aids 
Alertness tablets 
Analgesic/ pain relief 
Diuretics 





















32 - 100 
100 - 200 
100 - 200 
32- 65 
100 - 200 
16 - 30 
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There are many physiological effects of caffeine. It is known that the 
xanthines affect firstly the cortex and then the medulla, with large doses (500 
mg or more) stimulating the spinal cord. Many different systems and 
organs in the body are affected by caffeine consumption. These systems are 
the nervous system, urinary system, gastrointestinal system, cardiovascular 
system, respiratory system, endocrine and metabolic processes as well as the 
skin and appendages, so the effects are certainly widespread. 
There is a great deal of literature describing the effects of caffeine on 
the cardiovascular system. Increases in blood pressure have been reported 
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with acute ingestion of 150mg of caffeine (Ellinwood and Rockwell, 1988) 
but this effect is still inconclusive. Although there have been a few 
supportive cases for this (Robertson et al. 1978), a specific relationship 
between caffeine consumption and blood pressure has not been found. 
Caffeine stimulates the cardiac muscle causing an increase in the 
force of contraction, heart rate and cardiac output. In the other direction the 
medullary vagal muscle is also stimulated which has the opposite effect by 
decreasing the heart rate so that it can negate the increase by the cardiac 
muscle. As a result, bradycardia, tachycardia or no change may occur. 
Caffeine has also been implicated in myocardial infarction but there is little 
evidence for this. Cardiac arrhythmias also seem to be more common with 
high caffeine consumers (Greden, 1974) but the association has not been 
extensively studied. 
Coronary heart disease was found to be twice or three times more 
likely in men ingesting five or more cups of coffee per day according to La 
Croix et al. (1986). However other researchers ( James and Stirling, 1983) did 
not find this relationship. 
Gastrointestinal effects are another problem with caffeine ingestion. 
Nausea and vomiting can occur with large doses and hydrochloric acid 
secretion is stimulated by caffeine (Eilenhorn and Barceloux, 1988). As a 
result, stomach ulcers are more likely to occur. Decaffeinated coffee also 
stimulates gastric secretion, little is known about the effects of substances in 
coffee other than caffeine, therefore there may be another chemical in coffee 
causing deleterious effects (Curatalo and Robertson, 1983). 
Carcinogenic effects have also been proposed to occur with caffeine 
consumption athough this has not been well established. Pancreatic cancer 
has been the most suspected outcome but kidney and lower urinary tract 
cancer have also been suggested with seven or more cups of coffee per day 
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(James and Stirling, 1983). However there is no conclusive evidence for the 
relationship. 
The urinary system is affected by caffeine with both increased volume 
of urine and sodium excretion. This occurs because of a decrease in tubular 
resorption of sodium and water which can lead to a loss of fluids and 
electrolytes (Eilenhorn and Barceloux, 1988). Tolerance apparently develops 
to this response with chronic consumption. 
Metabolism is also affected by caffeine intake, Eilenhorn and 
Barceloux report that increases occur in metabolism with blood glucose 
levels (hyperglycemia) increasing as well. However, this appears to occur 
only in caffeine-naive people since tolerance develops in the chronic 
consumer. Curatolo and Robertson (1983) reported that an increase in free 
fatty acids 50 to 100 per cent occurs with acute caffeine. Respiratory rates are 
also known to be affected by caffeine. The medullary respiratory centre is 
stimulated which causes an increase in respiratory rate, oxygen 
consumption and carbon dioxide elimination (Sawyer, Julia and Turin, 
1982). 
Another effect of caffeine can be to change sleep patterns. Sleep onset 
is delayed (Revelle et al., 1980) and the quality of sleep is reduced at 
amounts of around 100 mg or greater by increasing stage two sleep, 
decreasing stage three and four and having variable effects on REM sleep 
(Curatolo and Robertson,1983). Again, tolerance develops to caffeine and 
sleep is less disrupted when chronically consumed. 
Effects on the nervous system are the most interesting for this study, 
and can be quite extreme ranging from problems of tremor, headache, 
anxiety, tenseness and irritability to caffeine psychosis with schizophrenic-
type symptoms. A condition termed caffeinism can also occur. Doses 
required for this need to be fairly high. Most reported cases have been 
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higher than 1000 mg. A greater description of caffeinism will be given later 
when discussing the psychological effects of caffeine. 
FACTORS MEDIATING CAFFEINE'S EFFECTS 
Some important factors which mediate the effects of caffeine must 
also be mentioned to understand the full effects that caffeine has on the 
body. These fall into the categories of tolerance, dependence, withdrawal 
and sensitivity to caffeine. 
Tolerance to caffeine appears to be an important factor in caffeine's 
effects. Examples of metabolic, urinary and sleep problems disappearing 
with chronic caffeine use exemplifies this. The mechanism for this caffeine 
tolerance however is not well understood. It has been suggested that an 
upregulation of adenosine receptors is the reason for tolerance developing. 
Boulenger et al. (1983) found that there was an increase in the number of 
adenosine receptors with tolerance. However, Holtzman, Mante and 
Minneman (1991) found that with tolerance developing to caffeine, there 
was no evidence for it being related to an increase in adenosine receptors. 
The adenosine antagonist activity of caffeine did not decrease and there was 
no difference between control and caffeine-treated rats in regard to 
adenosine binding sites in cerebral cortex despite increases in receptors. 
More work needs to be done to discover how the tolerance mechanism does 
work. 
The second factor influencing caffeine's effects concerns 
dependence.This is related to withdrawal as well. Both are characteristic of 
the heavy caffeine consumer. A physiological need often develops if the 
individual does not have their regular dose of caffeine. They will 
experience withdrawal, just as other drug abusers ~o when giving up an 
addiction. Withdrawal for the caffeine addict involves an onset at 12 to 24 
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hours after the last caffeine intake, peaks at 20 to 48 hours, and lasts about a 
week on average (Griffiths et al., 1988). Withdrawal involves a painful, 
generalized headache with associated discomfort including irritability, 
nervousness, decreased alertness, fatigue and sleepiness (Bruce et al., 1991). 
With caffeine consumption the symptoms disappear which clearly shows 
why people continue to ingest high quantities rather than abstain. 
Coffee drinking is a habit, like smoking, that many people are not 
willing to change. It is difficult for·them to do so since the morning cup of 
coffee is an integral part of their day, and coffee and tea drinking are also 
socially learned habits. Heavy consumers internally regulate the amount of 
caffeine they are drinking. Without consciously knowing they are doing so, 
they will increase the number of drinks they have if the caffeine content is 
lowered (Kozlowski, 1976). 
Sensitivity to caffeine also influences caffeine use. Individual 
differences exist in the responses to caffeine. One person may be able to 
drink six cups of coffee before any noticeable effects occur whereas another 
may only need three or four. This makes quantifying the effects of certain 
amounts of caffeine difficult, although taking body weights into account 
does improve this and is a far better indicator than simply referring to the 
effects of four cups of coffee. Sensitivity to caffeine must be taken into 
account when considering the tolerance effect which develops. It is easy to 
attribute a lack of caffeine effects to tolerance when in fact it is just 
individual differences that are responsible (Goldstein, Warren and Kaiser, 
1965). Perhaps heavy caffeine drinkers are not as sensitive to caffeine and 
can drink a lot more without any effects whereas those who do not drink 
very much caffeine do not because it does affect them more. This point has 
not been well studied, but tolerance is usually regarded as the reason for a 
fack of effects. 
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PSYCHOLOGICAL EFFECTS OF CAFFEINE 
The psychological effects of caffeine have been well documented and 
fall into the categories of performance, arousal, memory and mood. 
EFFECTS ON PERFORMANCE 
Caffeine improves mental and physical performance (Weiss and 
Laties, 1962). A review of a wide range of activities showed that caffeine can 
enhance many behaviours, such as working to exhaustion on a bicycle 
ergometer, all day hikes, driving a truck for 18 to 20 hours per day, athletic 
track events and motor coordination tasks. Sleepiness and motor tests were 
both enhanced with caffeine treatment compared with placebo but the effect 
was greater for sleepiness. Lokes, Hinrichs and Ghoneim (1985) reported 
that caffeine impaired fine motor coordination tasks because of hand 
steadiness. Weiss and Laties related the lack of hand steadiness to 
psychomotor agitation causing unsteady hand movements. Curatolo and 
Robertson (1983) also found that at low and high doses, caffeine may impair 
performance on complex motor tasks and fine motor coordination tasks. 
Reaction time appears to be reduced after 24 hours which may be due to 
CNS depression after the caffeine effects wear off (Cheney, 1936, Horst and 
Jenkins, 1935). 
Simple tasks such as arithmetic problems,typing and car driving 
which are all simple tasks, seem to be improved by caffeine at low doses 
(Regina et al., 1974). Other positive effects of caffeine include endurance and 
work capacity improvement but when the caffeine wears off, the 
countereffect of nervousness, irritability, sleep disturbance and fatigue 
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follows (Weiss and Laties, 1962). 
It appears that the effects on performance by caffeine are interactive 
and complex, performance has been found to be influenced by personality 
(Gilliland, 1980; Revelle et al. (1980). Different personality types may 
respond differently to caffeine. 
Increased alertness and wakefulness have been found with caffeine 
due to its stimulant effects. This may be dependent however on whether 
the person is a chronic caffeine consumer or not. Those that are caffeine 
naive experience more unpleasant effects and nervousness (Goldstein, 
Kaiser and Whitby, 1969). Sleep disturbances may also occur as described 
earlier. 
Effects of caffeine on memory are not well understood. Terry and 
Phifer (1986) have suggested that longterm memory may be altered by 
caffeine while Erikson (1985) thought that encoding the manipulation of 
information may be impaired. 
EFFECTS ON MOOD 
The effects on mood fall into the areas of anxiety and depression. 
Most studies on caffeine have been on acute effects and not many have 
considered chronic caffeine consumption which may be the more harmful. 
Anxiety can occur with either acute or chronic caffeine at high doses. 
Depression is usually associated with any anxiety effects. Panic anxiety in 
particular has been suggested to be affected by caffeine consumption as panic 
attacks have been found with high caffeine consumption (Charney, 
Heninger and Jatlow, 1985; Uhde et al., 1984). 
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CAFFEINISM 
Many studies have reported a relationship between high caffeine 
consumption and anxiety (Greden, 1974; Maccallum, 1979; Rapoport et al., 
1984). Doses of 500 mg per day (approximately 4 to 7 cups of coffee) or more 
can lead to symptoms of caffeinism which can be indistinguishable from 
anxiety neurosis. 
Greden (1974) reports three case studies of caffeinism, following 
consumption of 1000 mg or more per day. All three had symptoms of 
anxiety, tremulousness and headache. One had an irregular heartbeat while 
another suffered from insomnia. When they lowered their caffeine intake, 
scale ratings on the Hamilton Anxiety Scale returned to normal and the 
other symptoms also disappeared. All three went through withdrawal and 
when challenged after abstinence with high doses of caffeine, their anxiety 
returned. MacCallum (1979) published the case of a woman consuming 20 
or more cups of coffee per day (well over one gram) who complained of 
anxiety, panic attacks, cold sweat attacks, shortness of breath and a floating 
sensation. With the cessation of coffee drinking, the anxiety disappeared 
and she was left with the withdrawal headache and some dizziness. 
In addition to case studies, some empirical studies have been 
published. For example, Greden et al. (1978) looked at anxiety and 
depression in psychiatric patients. The State-Trait-Anxiety Index and the 
Beck Depression Scale were given to patients ranked as low consumers (0-
249 mg caffeine per day), moderate consumers (250-749 mg per day and high 
consumers (750 mg or more per day). The high consumers scored higher on 
the two measures and they also reported feeling more symptoms than the 
other consumers, and that they did not think their health was as good. They 
also reported using more sedative-hypnotics and minor tranquillisers. 
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A study by Gilliland and Andress (1981) looked for symptoms of 
caffeinism in psychology students. They put the students into categories of 
abstainers, low, moderate and high consumers. They administered 
questionnaires on the effects of caffeine, psychophysiological symptoms, 
state-trait anxiety, and depression. Moderate and high consumers reported 
more deleterious effects and the high consumers reported more 
psychophysiological reactions. Higher trait anxiety scores were obtained for 
the moderate and moderate and high combined and Semester grade point 
averages were higher in the abstainers than in the high consumer group. 
Shanahan and Hughes (1986) found that performance anxiety was higher in 
chronic caffeine drinkers given acute caffeine than it was in coffee drinkers 
given decaffeinated drinks. Veleber and Templer (1984) also found that 
subjects given a high dose of caffeine, 300 mg per 45.36 kg body weight 
scored higher on an anxiety and depression scale than those with a lower 
dose (150 mg per kg body weight) or no caffeine. 
Smith (1988) decided to look at the possibility of managing anxiety by 
reducing caffeine intake with anxious patients. He found that those who 
made reductions in their caffeine intake also had reductions in their 
anxiety, sleep disturbances, headaches, abdominal problems and their 
irritability. This brings into question the practice of providing coffee and tea 
freely in institutions when it may be prolonging the problems. Certainly it 
would be much better to discover if the anxiety problems of patients are 
related to caffeine rather than to treat them unnecessarily with drugs. 
BEHAVIOUR IN CAFFEINE EXPOSED ANIMALS 
Anxiogenic-like effects have also been found in rats (File and Hyde, 
1979; Baldwin et al. 1986, 1989) exposed to acute and chronic doses of 
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caffeine. Baldwin et al. (1986) tested rats both acutely and chronically over 
three weeks with two doses of caffeine. Two tests were used, the social 
interaction test and the elevated plus maze. The acute doses produced a 
decrease in interaction, and in rearing and a decrease in the en tries to the 
open arms. The chronically treated rats showed no change in social 
interaction or in entries to the open arms. The acute doses of caffeine 
produced effects which suggested anxiogenesis but the chronic treatment 
appeared to cause tolerance in rats. Holtzman (1983) also found that rats 
developed tolerance to chronic caffeine's locomotor stimulating effects 
which was reversible when caffeine administration was stopped. 
File et al. (1988) again found decreased social interaction and also 
reduced head-dipping, and less offensive aggressive behaviours in the 
home cage with an acute dose of 40 mg/kg. Motor activity was increased 
with 20 mg/kg. Chronic caffeine exposed rats did not show any differences 
from controls. This showed that the lower dose had a stimulant effect while 
the higher dose decreased exploratory behaviours. File and Hyde (1979) 
found an increase in motor activity with 20 mg/kg (ip) but a decrease in 
social interaction. Britton and Indyk (1990) tested rats in a novel open field 
and in the familiar home cage. The tests in the home cage showed that 
caffeine increased activity whereas in the open field, activity was lowered 
with doses of 5 and 10 mg/kg (ip). This suggests that it may be important to 
take the novelty of the testing apparatus into account when looking at the 
behavioural effects of caffeine. 
Katims et al. (1983) and Snyder et al. (1981) reported that a biphasic 
effect was found with caffeine at different doses. At low doses, activity is 
reduced while at high doses activity is increased. Baldwin and File (1989) 
also found evidence for anxiogenic-like effects in rats with a reduction in 
social investigation with doses of 20 and 40 mg/kg caffeine. 
Longterm anxiogenic effects have also been found in rats prenatally 
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or perinatally exposed to caffeine and this will be looked at in more depth in 
the next section. 
TERATOGENIC EFFECTS OF CAFFEINE 
Pregnancy is a time of great vulnerability to the unborn child. This is 
the time of most rapid development and the foetus is in direct contact with 
many of the same chemicals as its mother. Unfortunately the effects on the 
fetus are more detrimental. The nervous system in particular is susceptible 
to damage during both pregnancy and the early part of life, particularly 
when breast-feeding. Therefore effects of drugs on the unborn child are 
important to understand. Caffeine is an appropriate drug to study since 
many mothers would not consider the risk that caffeine could be to their 
child because it is so generally accepted. 
CAFFEINE ABSORPTION AND DISTRIBUTION 
Caffeine is readily absorbed from the gastro-intestinal tract with peak 
plasma levels occurring in 45 minutes to two hours. It is then rapidly 
distributed into body fluids with a volume of distribution of one litre per 
kilogram. After distribution, caffeine is eliminated from the body in urine 
when it has been metabolized by the liver. Caffeine is also eliminated via 
saliva, semen and breast milk, and is found in umbilical cord blood. Levels 
of caffeine in breast milk are only slightly lower than blood levels. The 
breast milk of a mother who has ingested 145.8 mg of caffeine, contains .82± 
.29mg/kilogram and the infant consuming this takes in about .027 to .203 
,ng of the drug (Eilenhorn and Barceloux, 1988). 
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The half life of caffeine in normal adults is 3 to 7.5 hours, but in 
pregnant mothers this time is lengthened, increasing until it is about 18 
hours in the last three months of pregnancy (Sobotka, 1989) thereby causing 
longer exposure to the infant. In newborns the half life of caffeine is 82 
hours (Aldridge et al., 1979). Most research suggests that caffeine should be 
avoided during pregnancy since the half life of caffeine in neonates can 
exceed 90 hours. As it is transmitted by the mother to the foetus, their blood 
level concentrations become similar (Gilliland and Bullock, 1984). 
PHYSICAL EFFECTS OF CAFFEINE ON HUMAN BABIES 
There are many reports of complicated deliveries of babies born to 
mothers consuming 600 mg of caffeine or more. Weathersbee (1977) found 
only one such mother out of 16 in a study, had an uncomplicated delivery. 
The other 15 pregnancies ended in spontaneous abortion, still and 
premature births.This is rather a high rate when 78.4 per cent of women 
who consumed no caffeine had uncomplicated births. Fenster et al. (1991) 
found an increased risk for low birth weight for mothers consuming 
caffeine. Those consuming a large amount (over 300 mg) were at double the 
risk of those in the unexposed group. Medium consumers of caffeine (151-
300 mg) had twice the risk of producing a baby with intrauterine growth 
retardation. Fathers may also be affecting pregnancy outcomes due to semen 
levels of caffeine, if they drink more than 600 mg of caffeine (Weathersbee, 
1977). 
PHYSICAL EFFECTS IN ANIMALS WITH PREN AT AL EXPOSURE 
In spite of some results suggesting that caffeine may be a teratogen, 
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there is no real evidence for this in humans, Weathersbee's study used a 
very select sample which may not have been representative of the general 
population. If we turn to the animal literature there are many more studies 
suggesting that caffeine is a teratogen. 
Gilbert and Pistey (1973) gave intraperitoneal injections to pregnant 
dams at doses ranging from four to 16 mg daily. Decreased birth weight and 
a greater number of resorptions occurred in groups given eight or 16 mg of 
caffeine. A decrease in litter size also occurred for these two groups. West et 
al. (1986) found reduced body weights in 50 and 70 mg/kg groups. Reduced 
body, liver and brain weight were found in offspring of rats with caffeine in 
their drinking water at a dose of 122 mg/kg/ day by Groisser et al. (1982). 
During lactation the pups recovered their weight difference, so that at 30 
days, they were similar to controls. Peruzzi et al. (1985) found no body 
weight change in perinatally caffeinated rats at doses of 27, 58 and 108 
mg/kg. 
Among the physical abnormalities that have been found with 
prenatal caffeine exposure are visceral and skeletal abnormalities, such as 
irregular and incomplete ossification of the skeleton and absence of 
supraoccipital bone (Fujii and Nishimura, 1972; Palm et al., 1978), 
hydrocephaly, oesophageal defect, edema, tail defects (Fujii and Nishimura, 
1972), delays in eye opening, incisor eruption and vaginal opening (West et 
al, 1986), cleft palate, lighter brains, liver and lungs (Palm et al., 1978). The 
doses given to the pregnant darns and the route of administration varied in 
these studies, but some physical damage to foetal rats is obvious. Fujii and 
Nishimura looked at caffeine effects at different stages of pregnancy and 
found damage seems to be confined to caffeine exposure at certain times 
during pregnancy. Most of the lethal and teratogenic damage occurred in 
the middle of pregnancy in their rats whereas edema was characteristic of 
the last part of pregnancy. 
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Brain abnormalities have been examined by a number of researchers. 
Nakamoto et al. (1986) have proposed that even when a small amount of 
caffeine is ingested by pregnant darns, this will affect the foetal brain because 
this is the time of greatest growth and development. Therefore it is more 
susceptible to influences such as caffeine. The cholesterol contents of the 
medulla oblongata, striaturn, rnidbrain and hippocarnpus were lower than 
controls, protein content was lower in the medulla oblongata and the DNA 
in the striaturn was also lower than controls. 
Yazdani et al. (1990) reported that different effects are displayed by 
different amounts of maternal caffeine ingestion. Foetal brain weights were 
heavier when the mothers ingested 2 rng/100 grams of bodyweight than 
when they ingested 0.Srng/100 grams. DNA concentrations were increased 
in the 0.5 mg exposed group whereas in the 2 mg exposed group the protein 
concentration was higher. 
Decreases in cyclic AMP were found by both Concannon et al. (1983) 
and Peruzzi et al. (1985). Even ten days after withdrawal from caffeine, the 
whole-brain levels were lower in the Concannon et al. study, whereas 
cerebellar cyclic GMP was elevated. However, this study was confined to 
postnatal caffeine exposure. 
The physical effects of prenatal caffeine exposure are numerous 
although not consistent, and may not be as important or common as 
behavioural changes. Many researchers have not found any evidence of 
physical abnormalities in the offspring of animals (Palm et al, 1978) in a 
similar fashion to what characterises human caffeine exposure. It is 
reasonable to expect that with caffeine effects on the brain, changes in 
behaviour will occur. This may be the more fruitful area to pursue. 
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BEHAVIOURAL EFFECTS OF CAFFEINE IN ANIMALS 
The behavioural effects of prenatal and perinatal caffeine have been 
mainly studied in rats and mice. It is more difficult to study behavioural or 
physical effects in humans due to ethical cosiderations. Retrospective 
studies are difficult to carry out because the amount of caffeine ingested is 
hard to determine when relying on self reports. People do not like to always 
admit that they have consumed a lot of caffeine if some adverse effects on 
their child has occurred. Therefore most research has focused on the rat. 
Considerable interest has arisen over the issue of whether or not 
pre/perinatal caffeine has longterm or permanent effects on offspring. The 
longer the period after birth that testing is carried out, the more likely that 
effects are permanent. Many researchers have tested rats at various time 
periods after birth. 
The research can be divided into areas of prenatal and perinatal 
caffeine exposure effects. A few studies have looked at postnatal exposure 
but most have focused on the other two areas combined. Within each 
division, further differences can be found in regard to the amount or dose 
levels given to the mothers. Other differences between studies which may 
confuse things are the route of administration of caffeine and the 
behavioural testing methods. These differences between the studies do 
make comparisons difficult but there are many trends that do emerge from 
them. 
One aspect of the experimental designs which makes the study more 
realistic for humans is the method chosen for administering caffeine. 
Studies which have provided caffeine in the female rats' drinking water are 
more relevant than those in which the drug has been injected daily. Palm et 
al. (1978) showed that the outcome on the offspring was different if the 
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caffeine was given in the drinking water than if it was injected in one dose 
every day. Physical abnormalities seem to be more prevalent when it is 
injected than when provided ad libitum in the drinking water. 
Crossfostering the offspring after birth is another practice which is 
often employed. This allows a much more conclusive study since it 
eliminates environmental effects from the mothers' altered behaviour 
because of the caffeine ingestion. Studies which have fostered the young 
generally support the idea that behavioural changes result from caffeine, 
and not just altered maternal behaviour. 
An inconsistency in the literature does exist regarding the dose levels 
of caffeine which are given to the mothers. Usually a low and a high dose 
as well as a placebo are used to allow for dose-response interaction, but the 
amount of caffeine in these two levels varies greatly. Sobotka (1989) 
reviewed a number of studies and found that the low dose ranged from 5 
mg/kg/ day to 60 mg/kg/ day. The high dose ranged from 35 to 180 
mg/kg/ day. As well as this problem, Sobotka also drew attention to the 
small number of studies that measure the blood levels of caffeine in the 
dams during exposure. This procedure would provide more accurate 
calculations of the amount of caffeine that is actually circulating in the rats. 
The method of testing used to look at the behaviour of rats has also 
been quite varied. Some of the tests employed are the open field test 
(Hughes and Beveridge, 1986 ; Sobotka et al., 1979; Glavin and Krueger, 
1985), emergence apparatus (Hughes and Beveridge, 1986), social interaction 
(File and Hyde, 1979; Holloway and Thor, 1984), elevated plus maze, passive 
avoidance task (Sobotka et al. 1974; File, 1987), photocell activity cages (West 
et al. 1986), running wheel activity (Butcher et al. 1984), righting reflex, 
swimming, chimney test (Peruzzi et al., 1985), holeboard test (File et al, 
1988), and spontaneous alternation (Sinton, Valatx and Jouvet, 1981). 
Within each of these different tests, the procedures also vary. The open 
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field test has been conducted in many different ways which has led to much 
criticism (Walsh and Cummins, 1976). Most tests however are used to 
measure activity or emotionality and a fair amount of consistency is found 
in the results. 
PRENATAL CAFFEINE EFFECTS 
There are a great number of studies which have looked at the effects 
on the offspring of maternal caffeine exposure during pregnancy alone. 
Hughes and Beveridge (1986) tested their rats at various ages (61, 145 and 188 
days) in an open field after dams had been injected during gestation with 
doses of 10, 20, or 40 mg/kg or with distilled water. When younger, rats 
tended to have increased locomotor activity and male rats exposed to 40 
mg/kg walked significantly more than those exposed to 20 mg/kg or 
controls. As they became older, rats groomed more and stayed in the 
corners, suggesting a more emotional/fearful reaction. The pregnant dams 
in this research were injected intraperitoneally with caffeine. Later, Hughes 
and Beveridge (1987,1990) changed their method of caffeine administration 
by providing it in the drinking water. Three ages of testing were again used 
in the 1987 study, 73, 117, and 171 days. The doses given to the female rats 
were 24 or 44 mg/kg and tap water alone for the controls. Decreased 
locomotor activity was found at the high dose for all ages and females' 
defecation decreased while more males failed to emerge with the high dose. 
These results are suggestive of greater emotional reactions with the high 
dose of caffeine. 
Biphasic effects have been found with caffeine doses. Often a low 
dose will increase activity and decrease emotionality while a high dose 
decreases activity and probably increases emotionality. Further evidence for 
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this was heavier adrenal glands in females exposed to 36 mg/kg/ day of 
caffeine than controls. Adrenal glands are known to grow in rats exposed to 
stressful situations (Hughes and Beveridge, 1990). Doses used were 28 and 
36 mg/kg. Lombardelli et al. (1984) also found a biphasic effect in rats. This 
occurred for both perinatally exposed rats and controls. Activity increased 
with a maximum peak at 30 mg/kg caffeine exposure and then decreased 
with higher doses of 60 mg/kg. The perinatal caffeine rats had lower 
activity at both points than controls, so that the main effect was depressed 
activity in the perinatally treated rats compared with controls. Butcher et al. 
(1984) also found increases in running wheel activity with low doses of 
prenatal caffeine and decreases with the high dose. This effect seems to be 
specific for prenatal and perinatal caffeine treatment. With acute postnatal 
treatment the opposite is found. Snyder et al. (1981) have reported that 
caffeine reduced activity at lower doses of five and ten µmol/kg while 
stimulating activity at higher doses of 30 and 100 µmol/kg. The effects 
found with prenatal exposure must be due to longterm changes in the brain 
rather than an effect of withdrawal or presence of caffeine in the brain as 
this occurs long after caffeine exposure has stopped. 
Glavin and Krueger (1985) found no significant differences between 
controls and prenatal caffeine-exposed rats in open field ambulation or 
defecation, but they did find that rats who were exposed to the high dose (0.5 
mg/ml) had more (and bigger) gastric ulcers than did controls. This agrees 
with the results of Hughes and Beveridge suggesting that increased 
emotionality (anxiety/ fear) occurred. 
Sinton, Valatx and Jouvet (1981) have also found evidence for 
behavioural teratogenic effects in mice. An increase in passive avoidance 
latencies at doses of 60, 80 and 100 mg/kg/ day was found along with an 
increase in open field activity in female mice only. West et al. (1986) also 
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found an increase in passive avoidance with a prenatal caffeine dose of 50 
mg/kg/ day. At lower doses, 5 and 25 mg/kg/ day, passive avoidance was 
decreased. 
Concannon et al. (1983) gave rats caffeine prenatally (14.24 mg/kg/ day 
average), postnatally (52.23 mg/kg/ day) or during both times (39.41 
mg/kg/ day) in the darns drinking water. The postnatal caffeine group has 
lowered activity at 15 days and the perinatal and postnatal groups both 
showed lowered activity from day 20. Postnatal caffeine therefore seems 
important in reducing activity. At 25 days the postnatal caffeine treatment 
stopped and by 35 days only the prenatal caffeine group had reduced activity. 
This indicates that prenatal caffeine gave longerlasting behavioural effects 
than postnatal caffeine. 
PERINATAL CAFFEINE EFFECTS 
Perinatal caffeine effects have not been tested very often, but a few 
studies do exist. They give a better indication of what might really happen 
since most human mothers would continue to drink caffeine while breast-
feeding if they had done so throughout pregnancy. 
Sobotka, Spaid and Brodie (1979) exposed rats to caffeine in their 
drinking water during pregnancy. The exposure doses to the offspring were 
23, 49, and 92 mg/kg/ day during gestation and 37, 75, and 138 mg/kg/ day 
during lactation. Perinatal-caffeine exposed rats at all doses had increased 
rearing in an open field. Ambulation was also increased in the low and 
middle dose groups. Stress responses were not affected. 
Peruzzi et al. (1985) used caffeine dose levels of 0, 27, 58, and 108 
mg/kg/ day during gestation and 0, 49, 103, and 188 mg/kg/ day during 
lactation. Behavioural tests revealed that start latencies were increased in all 
caffeine treatments, the number of squares entered were reduced for all but 
22 
the high dose, sniffing and rearing was decreased. Only the sniffing and 
rearing measures were significantly different from controls. Effects were 
strongest for the lowest doses and as the doses increased they became more 
like controls. The rats in this study were tested before they were withdrawn 
from the caffeine treatment and this can confound the results. Sobotka et al 
(1979) mentioned above tested the rats after they were weaned so their 
results are not comparable with Peruzzi et al. Concannon et al. (1983) 
measured the rats' behaviour at several time periods and did find 
hypoactivity ih preweaned rats which is consistent with the Peruzzi et al. 
study. 
Hughes and Beveridge (1991) have completed a study directly 
relevant to research which will be presented in this thesis, as the rats used 
in this study were siblings of those tested by Hughes and Beveridge. The 
investigation by Hughes and Beveridge was similar to the Concannon et al. 
(1983) study. Rats were given caffeine during gestation, lactation or both. 
Doses of 0, 26 and 45 mg/kg/ day were provided for dams in their drinking 
water during gestation and in lactation the doses were 0, 25, and 35 
mg/kg/ day. The difference between the gestational and lactational doses 
were due to differences in the amount of water ingested during the two 
time periods. The rats were tested at various ages. These were one, two, 
four and six months after birth. 
Rats in the gestation group only were affected in the following way: 
1) Males with the low dose walked less than controls or the high 
dose. 
2) Less rearing occurred for two and four month old rats at the 
high dose. 
3) Ambulation was greater for males at both caffeine doses. 
4) Rats exposed to the low dose had greater latencies or failed 
to emerge more of ten. 
Rats in the lactation group only were affected in the following way: 
1) Rats exposed to the low dose reared less often 
2) Less ambulation occurred in the high dose male group. 
3) Males in the low dose group defecated more than those in the 
high group 
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More behaviourally significant results were obtained for the rats that 
were perinatally exposed to caffeine. This suggests that caffeine exposure 
during both gestation and lactation has greater effects on the offspring than 
during one period alone. 
1) Rats exposed to low or high doses had higher walking than 
controls 
2) Rearing was lower with both doses than with controls. 
3) Ambulation was lower in both dose treatments. 
4) Greater defecation occurred for both dose exposed rat group 
but only when tested at six months of age. 
5) A greater number of rats in the two caffeine dose groups took 
longer to emerge or failed to emerge than the controls. 
A significant finding in this last group was the loss of male only 
effects which were evident in the lactation only and gestation only 
conditions. Activity was reduced for both dose levels of caffeine in the 
perinatal group in every case whereas the the prenatal and postnatal groups 
were usually affected by one dose only. This suggests a. greater additive 
effect of caffeine when exposure occurs in both gestation and lactation. 
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The measures suggest that decreased activity and increased 
emotionality, may characterize the effect caffeine has on these rats. 
EXPLANATIONS FOR CAFFEINE'S EFFECTS 
Reasons for the behavioural effects which have emerged in the data 
have been sought by many investigators in an attempt to discover how 
caffeine influences behaviour and the brain. The behavioural changes 
appear to be long lasting. They last at least eight months as found by 
Hughes and Beveridge (1990), so it is important to understand implications 
for human beings. 
There have been many theories proposed to account for caffeine's 
effects, some accounting for the stimulant properties of caffeine and others 
looking at the anxiogenic effects of caffeine. The main ones involve 
phosphodiesterase action, dopamine system interaction for the stimulatory 
effects and, for the anxiogenic effects, increased catecholamine activity, 
benzodiazepine receptor blockade and adenosine receptor blockade. 
PHOSPHODIESTERASE INHIBITION 
A mechanism proposed to explain caffeine's stimulant effects is the 
inhibition of phosphodiest~rase. This enzyme is responsible for changing 
the shape of the protein on the neuronal membrane gate. If 
phosphodiesterase is inhibited, cyclic AMP accumulates which results in the 
ion gates staying open. Caffeine has been found to inhibit 
phosphodiesterase so that this situation does occur and this has been the 
proposed mechanism responsible for caffeine's stimulant and wakefulness 
effects. Apart from phosphodiesterase, the neurotransmitter seratonin can 
prolong cyclic AMP which may also show an increase with caffeine. Drugs 
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such as buspirone, which is an anti anxiety drug, may perhaps vmrk 
through this mechanism. 
This phosphodiesterase hypothesis has problems. Peruzzi et al. 
(1985) and Concannon et al. (1983) found that cyclic AMP levels were 
actually decreased rather than increased with perinatal caffeine treatment 
which argues against this mechanism being involved. The concentrations 
of caffeine that would be needed for phosphodiesterase inhibition to have 
any effect are far greater than the amount of caffeine that is found in the 
brain at effective doses (Smellie et al., 1979). Another problem is that other 
phosphodiesterase inhibitors do not show the same behavioural effects as 
caffeine and some are central depressants (Beer et al., 1972). 
DOPAMINE 
The involvement of dopamine in the effects of caffeine has been 
suggested. Boehne and Ciarenello (1981) found that activity was influenced 
by dopamine receptor concentrations. Sinton, Valatx and Jouvet (1981) have 
suggested that systems related to anterior forebrain dopamine systems may 
be changed by caffeine given during gestation. They report one study in 
which caffeine during gestation resulted in a decrease in dopamine in the 
locus coeruleus. However, Concannon et al. (1983) found no effect on 
dopamine levels with caffeine exposure pre and postnatally. The 
relationship of dopamine is unclear. 
CATECHOLAMINE ACTIVITY 
Norepinephrine (NE) is known to increase with caffeine 
administration (Charney et al., 1984; Charney, Heninger, and Jatlow, 1985). 
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Robertson et al. (1978) found increased levels of NE in the plasma and urine 
of humans. Animal studies have also found an interaction behveen 
caffeine and NE function (Corrodi et al., 1972). 
Norepinephrine effects peripheral autonomic synapses (Sawyer, 
Julia, and Turin, 1982). In many anxious patients, peripheral NE 
hyperactivity is displayed. These are the somatic symptoms of anxiety 
including palpitations, stomach butterflies, tremulousness, and 
hyperventilation. The relationship between caffeine's anxiogenic properties 
and these symptoms has been explained as NE increase. In particular, panic 
anxiety has been associated with this hypothesis due to the symptoms 
experienced in a panic attack (Charney et al., 1985). Beta blockers have been 
utilized medically in light of this peripheral NE proposal because they 
decrease NE activity possibly by both central and peripheral blockade (Hayes 
and Schulz, 1987). 
However, a problem with this hypothesis exists because many studies 
have failed to find increased levels of plasma MHPG, the major metabolite 
of NE (Charney et al., 1985; 1984; Concannon et al., 1983; Uhde et al., 1984). 
This could be explained by the fact that at low doses of caffeine, MHPG 
levels do not increase and at higher doses only a twenty per cent increase of 
MHPG may occur (Charney et al., 1984). If small increases occur in MHPG in 
regional brain NE turnover, this may not be reflected in total brain or 
plasma MHPG levels. 
One brain region which is implicated in regulating anxiety, is the 
locus coeruleus, a nucleus in the brainstem. This region contains 70 per 
cent of the brains noradrenergic neurons and projects to the limbic system, 
cerebral and cerebellar cortices (Hayes and Schulz, 1987). This gives support 
to the role NE may play in anxiety and in caffeine's effects in anxiety. What 
is not really understood however, is the way that beta blockers exert their 
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action. They may be blocking only the peripheral beta sites or they may also 
act centrally. Most studies do suggest that they act on the periphery 
(Hughes, 1981), but they may act centrally as well by inhibiting the NE 
system via the locus coeruleus or indirectly by peripheral blockade and 
feedback to the brain. Direct blocking of beta-adrenergic impulses may also 
occur (Noyes, 1982). 
The importance of NE in caffeine's anxiogenic effects is still unclear. 
The lack of positive increases in MHPG has made the involvement more 
difficult to find which has led many researchers to regard it as less likely 
than other brain systems. 
BENZODIAZEPINE RECEPTORS 
Benzodiazepine receptor antagonism is a popular hypothesis to 
explain caffeine's behavioural effects. The benzodiazepine drugs are very 
commonly used to alleviate anxiety. These benzodiazepine drugs act on 
the benzodiazepine -receptor- GABA complex (Uhde, Tancer and Gurguis, 
1990). The effects that caffeine have on the benzodiazepine receptor have 
been very mixed. Caffeine was found to antagonize diazepam's central 
effects which suggests that it is blocking the benzodiazepine receptor. 
Caffeine was found to increase (Wu and Coffin, 1985; Boulenger et al., 
1983)the numbers of benzodiazepine receptors but Marangos, Boulenger and 
Patel (1984) found no increase in benzodiazepine receptors from day 16 to 23 
of caffeine treatment while they were increased up to day 16. Even if the 
benzodiazepine receptor is not antagonized by caffeine, benzodiazepine 
action may be antagonized at the adenosine receptors or an unknown site 
(Wu and Coffin, 1985), or it may even occur at both sites. Phillis and Wu 
(1981) have shown that benzodiazepines block adenosine reuptake therefore 
allowing endogenous adenosine to accumulate extracellularly. The 
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benzodiazepines' sedative and muscle relaxant effect was suggested as being 
due to the increase in extracellular adenosine (Clanachan and Marshall, 
1980). This last possibility can not be ruled out, according to Bruns et al. 
(1983). 
Wu and Coffin looked at the withdrawal effects from chronic 
caffeine at the benzodiazepine receptor site and the adenosine receptor site. 
A 30.9 per cent increase in diazepam binding and a 120 per cent increase for 
the adenosine agonist PIA was found. This may indicate a lower affinity for 
benzodiazepine receptors than adenosine receptors. Wu and Coffin's 
conclusions were that both the benzodiazepine and adenosine receptor sites 
may be affected by chronic caffeine and therefore, both may be responsible 
for the behavioural effects found. 
Snyder et al. (1981) decided that caffeine's behavioural effects are 
unlikely to be mediated at the benzodiazepine receptor site because the 
"methylxanthines are 100 times more potent at the adenosine than 
benzodiazepine receptors and no correlation exists between behavioural 
potencies and effects at benzodiazepine receptors." Marangos et al. (1981) 
also found the benzodiazepine receptor to be an unlikely site for caffeine's 
behavioural effects because the levels of caffeine required to affect them are 
found at convulsant doses of caffeine (Marangos et al., 1981). So, most 
evidence points to the adenosine receptor site for the behavioural effects. It 
may be that benzodiazepines do help to potentiate the adenosine as Wu and 
Coffin felt or it may be that caffeine affects adenosine alone. 
Commissaris et al. (1990) reported that benzodiazepines do not appear 
to exert their effects by inhibiting adenosine reuptake which has been 
suggested since two adenosine agonists, I-PIA and NECA both failed to 
effect a behavioural test which is sensitive to benzodiazepines. If increased 
adenosine was occurring with the use of benzodiazepines then one would 
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expect these analogs to have a similar effect. 
The interaction between benzodiazepine and adenosine appears to be 
small. There are no direct receptor interactions. Adenosine and 
benzodiazepines do not seem to affect each other's receptor sites. There may 
be some influences on the output of adenosine by benzodiazepine. 
Therefore, adenosine appears to be more important in caffeine's effects 
than the benzodiazepine receptors. 
ADENOSINE RECEPTORS 
The strongest explanation for caffeine's anxiogenic effects involves 
adenosine receptors. 
Adenosine is a purine nucleoside. It is present in many brain areas as 
well as existing in the periphery. Adenosine is best described as having a 
neuromodulatory role although it does have neurotransmitter-like 
properties but does not fill all the criteria for a neurotransmitter. As a 
neuromodulator it affects neurotransmitters mainly in an inhibitory 
fashion. Adenosine has been recognised as playing an important role in 
controlling excitability, having a sedative effect. Katims, Annau and Snyder 
(1983) found that sedation occurred with direct administration of adenosine 
to the brain. Locomotor activity is also reduced by adenosine and this effect 
is biphasic, which may possibly implicate an involvement of the differential 
effects of the Al and A2 receptors (Williams, 1987). 
There are three adenosine receptor sites which have been identified. 
They are called the Al, A2 and Preceptors. At present, the Preceptor is not 
very well understood. Both the Al and A2 have been studied more 
extensively and are better understood although there is still a lot to learn. It 
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is known that Al and A2 receptors are situated extracellularly and have 
effects on adenylate cyclase, an enzyme which is responsible for production 
of cyclic AMP. Al receptors inhibit adenylate cyclase whereas A2 receptors 
stimulate it. This influence on adenylate cyclase may be responsible for the 
sedating role of adenosine. Al will cause more stimulation by inhibiting 
adenylate cyclase which will produce cyclic AMP causing the ion gates to 
remain open, whereas the A2 receptors increase the adenylate cyclase 
therefore having the opposite effect and sedating the individual. This 
relationship is complex however, because both Al and A2 agonists cause 
sedatory effects. 
Caffeine appears to antagonize both Al and A2 receptors. Following 
caffeine administration, adenylate cyclase is sensitized to adenosine 
according to Stiles (1986). Furthermore the caffeine dose required to affect 
adenosine receptors are well within the stimulant dose range in rats (Snyder 
et al., 1981). Chronic treatment with caffeine has also been found to cause 
an increase in adenosine receptor numbers (Boulenger et al., 1983). 
Marangos, Boulenger and Patel, (1984) have examined the 
relationship between adenosine and caffeine consumption, in particular 
looking at the receptor upregulation and distribution in the brain in mice, 
on a daily basis, exposed perinatally to chronic caffeine. There animals were 
given caffeine doses equivalent to 4 to 5 cups of coffee per day in humans 
when surface area and metabolic differences are taken into account. 
Increased numbers of receptors were found at day 11 but not earlier 
and the mice were weaned at day 14. Therefore, they concluded that caffeine 
during lactation was sufficient to increase the number of adenosine 
receptors. No postweaning/ post caffeine tests were made. Since all 
measurements were during caffeine exposure there was no evidence of 
longterm changes to adenosine receptors, although this has been suggested 
as the reason for the longterm behavioural changes. The altered adenosine 
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receptors found in this study were certainly consistent with studies showing 
behavioural changes with perinatal treatment, even though this study did 
not measure behavioural changes. 
The adenosine uptake site was not affected by the chronic caffeine 
administration which confirmed the belief that the uptake site and receptors 
are separate and have different regulation. This lack of uptake receptor 
effects may also provide more contrary evidence for benzodiazepines acting 
via the adenosine system. Areas of the brain that showed adenosine 
receptor increases were the cerebellum and brainstem to the greatest extent. 
The cerebral cortex and the thalamus were not as easily influenced, no 
significant differences in these regions were found until day 23. 
Surprisingly, the adenosine receptors in the hippocampus where receptors 
are normally very dense, were not increased. 
Snyder et al. (1981) took the relationship of caffeine with adenosine 
one step further and investigated whether behavioural effects of xanthines 
occurred with increased adenosine receptors at acute doses of caffeine. They 
found that increased locomotor activity correlated with the increases in 
adenosine receptors labelled with 3H - CHA suggesting that the stimulatory 
effects of caffeine are related to adenosine upregulation. 
Adenosine analogs can be useful for determining if the effects of 
adenosine are the same as when levels have been increased in the way 
suggested with caffeine ingestion. Snyder and Sklar (1984) used two of these 
analogs, CHA and PIA. Both are specific Al agonists. At low doses, 0.1 
µmol/kg (ip) I-PIA was found to reduce locomotor activity. Lower doses 
than 0.1 µmol/kg (.005 to .001 mg/kg) lead to stimulation of locomotor 
activity (Katims et al., 1983). Even when doses are 500 times greater than 0.1 
mg/kg, mice remain awake and lethal effects do not appear to exist, even at 
800 µmol/kg (Snyder et al., 1981). Dunwiddie (1985) points out the 
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importance of intracerebroventricular injections to get a clear picture of 
effective doses. This is because of the 0.02 to 0.05 mg/kg (ip) range he 
reported as exerting depressant effects, only lOnM or less entered the brain. 
If depressant doses of L-PIA and caffeine are given together the effect 
is a 300 per cent stimulation. This is probably because some sites have high 
affinity for L-PIA and these characterise the stimulatory effects. Other sites 
have lower affinity and display depressant effects. Xanthines may block 
these lower affinity sites for L-PIA and thus the stimulant effects are brought 
out by L-PIA at the high affinity sites (Snyder and Sklar, 1984). 
Boulenger et al. (1987) found some indirect evidence for adenosine 
being involved in the anxiogenic effects of caffeine in humans. Caffeine 
levels which produced anxiety (720 mg) are in the range k~own to compete 
with the binding of various ligands to the adenosine receptors in the 
human brain. They failed to find elevated plasma adenosine levels but this 
may be due to the fast reuptake of adenosine when displaced from brain 
receptors. 
Adenosine upregulation is certainly the most likely theory to explain 
the anxiogenic effects of caffeine. However, there are problems, in 
particular, the fact that reduced activity (found with perinatal caffeine) is 
consistent with increased adenosine, whose major function appears to be 
sedative. Thus, the increased emotionality/ anxiety would not be expected. 
More needs to be known about adenosine's actions and the interaction with 
caffeine. It may be that different receptors are involved or that adenosine 
interacts with other neurotransmitter systems. 
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HYPOTHESES IN THIS STUDY 
Perinatally caffeine treated rats will have different behaviour to rats 
who have not been exposed to caffeine. As demonstrated earlier (Hughes 
and Beveridge, 1991), this will be shown as decreased locomotor activity 
measured by ambulation, walking, rearing and amount of time spent still. 
Increased emotional effects may be evident by increased defecation, higher 
corner occupancy and a longer emergence latency from a dark to an 
illuminated area. 
The use of drugs, mainly antianxiety, which have affinity for specific 
brain receptors will give differential effects for the control, low and high 
perinatal caffeine groups. This will assist in discovering which brain 
mechanisms are involved in the behavioural effects of perinatal caffeine 
exposure. 
Administration of caffeine in acute doses will show differences 
between the groups as there may be tolerance effects which are longlasting 
or a permanent change in the brain which may cause a difference in 
caffeine's influences on caffeine-exposed rats. 
RATIONALE 
This experiment is a continuation of research by Hughes and 
Beveridge (1991) on the behavioural effects of perinatal caffeine exposure in 
rats. They found differences between the groups; the caffeine groups 
showed reduced activity and signs of increased emotionality when observed 
in the open field. The inference was that a permanent change in the brains 
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of these animals may have occurred. It was suggested that a likely reason 
for this was an upregulation of adenosine receptors, based on findings by 
other researchers that have already been mentioned. 
This study is a continuation of the original, in which untested 
siblings were further investigated by observing the effects of specific drugs 
in order to gain a better understanding of perinatal caffeine effects in rats. If 
the mechanisms responsible for behavioural changes caused by caffeine 
could be discovered, this would assist in the reversal of problems which 
may exist in humans exposed to caffeine during pregnancy and while 
breast-feeding. 
The behavioural test employed was similar to that used by Hughes 
and Beveridge. This seemed the most logical way to conduct the 
experiments, so that the findings could be consistent and related to the 
original study. The open field arena is a useful test method for observing 
behavioural effects. While it is a simple test which gives results fairly 
quickly, it has been criticized for its simplicity and because there is no 
standard open field apparatus. The arena can be any shape (usually circular 
or square) and any size. Other inconsistencies exist in regard to the time 
sampling of observations, the definition of the measures used and in the 
lighting and noise levels employed (Walsh and Cummins, 1976). However, 
it is a test which allows the animal relatively free choice in its movements 
which is important when measuring behaviour. The less disturbance of the 
animal the more natural its behaviour will be. It is a useful test for 
acquiring some idea of the animal's behaviour from which further, perhaps 
more rigorous, tests can be employed. 
The behavioural measures chosen were indices of activity and fear. 
Walking and ambulation are usually related measures of activity with the 
amount of time spent still showing an expected inverse relationship. 
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Rearing also shows the level of excitability and has been described as 
possibly being more of an escape response, whereas walking and ambulation 
may be exploratory in function. Grooming is usually negatively related to 
high activity. Higher grooming is regarded as indicative of increased fear, 
acting as a displacement behaviour. Defecation is probably the most reliable 
measure of emotionality. Immobility and freezing are also signs of stress, 
and corner occupancy, rather than centre occupancy is an index of timidity 
(Archer, 1973). 
The drugs employed in this study were caffeine, diazepam (a 
benzodiazepine anti-anxiety drug), Chlorohexyladenosine (CHA, an 
adenosine Al agonist) and oxprenolol (a Beta blocker). This type of study 
has not been caffeine effects and previously carried out. 
Baldwin and File (1989) have looked at behavioural effects of acute 
caffeine and the possible brain mechanisms influencing this. They used 
similar drugs influencing the same receptor populations in the brain but 
they measured social interaction effects. There study is not comparable to 
this one because of the known differences between acute doses of caffeine 
and chronic perinatal exposure. 
Rats are suitable animals for this investigation because of their 
availability and the past work done with them. Rapid results are obtainable 
and most importantly, the data is not retrospective and reliant on self 
reports. The ethical problems of studying humans in this light are also 
obvious and virtually impossible to do at this time. 
ANIMALS 
CHAPTER TWO 
METHODS AND MATERIALS 
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Subjects were 72 Wistar rats, exposed to caffeine perinatally through 
their mothers' drinking water during gestation and while lactating. All rats 
had been bred by Hughes and Beveridge (1991) for another purpose. The 
particular subjects used in this study had not been tested previously. There 
were three different condition groups: the mothers' of one group received 
only tapwater during pregnancy and lactation. Their offspring comprised 
the control group. A second group received 26 mg/kg/ day caffeine added to 
their mother's drinking water during gestation, and 25 mg/kg/ day during 
lactation (low dose). The third group received a high dose of caffeine via 
their mothers' drinking water which contained 45 mg/kg/ day during 
gestation and 35 mg/kg/ day during lactation. The rats were also 
crossfostered during this process to control for effects by the darns. All rats 
were born at the same time and tested approximately 9 months after birth. 
HOUSING 
The rats were housed in groups of three in single sex cages. Food and 
water was made available to them at all times and they were kept in a 12-hr 
light: 12 hr dark cycle, and tested during the dark cycle. The rats were 
sprayed with nontoxic dye for identification purposes. 
DRUG TREATMENT 
Injections were given intraperitoneally , in a volume of 1 ml/kg. 
Each rat received five injections over the course of the experiment. 
Injections were given at least one week apart, and the order of drug 
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administration was varied. 
The drugs used were saline (isotonic solution), Diazepam at two 
doses (1 and 2 mg/kg bodyweight), caffeine (10 and 20 mg/kg bodyweight) 
Chlorohexyladenosine (CHA, 0.05 and 0.1 mg/kg bodyweight) and 
oxprenolol at two doses (10 and 20 mg/kg bodyweight). After injection of 
the drug, the rat was left for 30 minutes before testing. 
APPARATUS 
A square open field arena was used, measuring 60cm x 60 cm and 
with 30 cm high walls. The black perspex floor was divided into 16 squares 
which were numbered accordingly. A lamp with a circular fluorescent tube 
was placed above the open field to provide equal light over the whole arena. 
An emergence apparatus was also used, consisting of a small dark 
room, 20 cm x 15 cm with 20 cm high walls, separated from a larger box, 50 
cm x 40 cm with 20 cm high walls, lit by two fluorescent tubes in the floor. 
There was a sliding door in between the two rooms which allowed access to 
each when opened. 
White noise was used to mask outside noises and was kept at a level 
of 58dB for the entire time that the rats were in the testing room. A 
handheld beeper was used, which sounded every five seconds through an 
earplug which only the experimenter could hear. A stopwatch was also 
used, to record latency to emerge from the emergence apparatus. 
PROCEDURE 
The rats were placed into two independent groups, split equally to 
contain the same number of each condition group and sex. This formed 
two separate experiments. 
Experiment one consisted of testing the 36 rats with saline, the two 
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doses of diazepam, and of caffeine. A repeated measures design was used so 
that every rat experienced each different dose over a five week period but in 
a different order. A week intervened between each test to ensure that the 
drug effects had dissi ppa ted and also to reduce familiarity of the test 
procedure. The experiment was conducted using a single blind testing 
procedure. The treatment group for each rat was only revealed after all 
testing had been completed. 
For ease of testing, all three rats in each cage were tested in 
succession. Therefore rats in the same cage were always tested on the same 
day, usually within the same hour. 
Experiment two was conducted in the same manner but different 
drugs were used. These were saline, chlorohexyladenosine at low and high 
dose and oxprenolol at low and high dose. 
Once injected, rats were left for 30 minutes in their cage before being 
placed by hand into the centre of the open field. They were observed for 5 
minutes at 5 second intervals, when their behaviour was noted. The 
number of the square they were occupying was also written down. After 
five minutes the rat was removed from the open field, the number of faecal 
boli were counted and it was placed into the small dark box of the 
emergence apparatus. The sliding door was then opened and a stopwatch 
started. The time for emergence, defined as the complete entry into the lit 
area of the emergence box, was noted. If the rat failed to emerge within five 
minutes, this was recorded as "failed to emerge." The rat was then placed 
back into its cage and left for at least a week before retesting with a different 
drug or dose. 
After each rat had completed its test, the open field and the 
emergence apparatus were washed down with soapy water to prevent the 
possibility of olfactory cues influencing later rats' behaviour. 
DEFINITION OF MEASURES 
1. Ambulation was measured by noting the square a rat 
occupied. Both back feet had to be in the square. 
2. Corner Occupancy involved being in one of the four corner 
squares. 
3. Centre Occupancy involved occupying one or more of the 
four centre squares. 
4. Defecation was measured by counting the number of boli . 
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5. Emergence latencies comprised fully moving from the dark to the 
lit area was timed. 
6. Grooming involved licking, washing, or with front paws over face. 
7. Rearing was defined as standing up on hind legs either in 
mid air or against a wall. 
8. Still behaviour involved not moving but they could be 
sniffing and/ or moving their head. 
9. Walking involved locomotion while observed. 
DATA ANALYSIS 
Three way ANOV As were performed for each drug (dose x sex x 
perinatal caffeine group) for the measures of ambulation, centre occupancy, 
corner occupancy, defecation, emergence, grooming, still, rearing and 
walking. 






Effects on behavioural measures, with administration of saline, 
diazepam and caffeine doses after perinatal caffeine exposure, for each sex 




There was an overall sex effect, F(l,29) = 13.062, p< .005. This was 
due to higher ambulation by females, (females = 38.574 ± 1.288, males = 
30.255 ± 1.885). 
A dose effect was also present, F(2,58)= 36.630, p< .001. Lowered 
ambulation occurred with the high dose of diazepam compared with the 
saline and low dose: the mean for the saline group was 39.8 ± 1.933, the low 
dose, 39.114 ± 1.993 and for the high dose, 24.686 ± 1.364. 
These two effects further interacted to produce a sex x dose 
interaction, F(2,58) = 3.187, p< .05. As with the overall effects, a dose effect 
for males, F(2,58) = 11.339, p< .0001, showed lower ambulation with the high 
dose of diazepam than with the saline or low dose of diazepam. The saline 
dose mean was 35.824 ± 2.861, for the low dose it was 32.118 ± 2.811 and for 
the high dose, 22.824 ± 1.85. 
A dose effect for females also existed, F(2,58)= 29.139, p<.0001, the high 
dose of diazepam resulting in lower ambulation than saline or the low dose. 
Means were 43.556 ± 2.356 for saline, 45.722 ± 1.49 for the low dose and 26.444 
41 
± 1.956 for the high dose. F(2,17)= 33.667, p,.0001. 
The interaction was due to no sex effect for the high dose, but males 
had lower ambulation than the females for the saline dose F(l,78)= 5.323, 
p<.05 and the low dose of diazepam, F(l,78)= 17.546, p< .0001. Means for the 
saline dose were 35.824 ± 2.861 for males, 43.556 ± 2.356 for females. For the 
low dose, males scored 32.118 ± 2.811 and females, 45.722 ± 1.49. 
CENTRE OCCUPANCY 
An overall dose effect was present, F(2,58)= 8.221, p< .001. There was 
decreased centre occupancy with the high dose compared with saline and the 
low dose ( saline mean = 5.457 ± .737, the low dose = 6.771 ± .89 and the high 
dose= 3.114 ± .508). 
A perinatal caffeine effect also occurred, F(2,29)= 4.438, p< .05, the 
control group having lower centre occupancy than the low perinatal caffeine 
group and the high perinatal caffeine group, ( the control group mean = 
3.303 ± .475, low perinatal caffeine group = 5 ± .582 and the high perinatal 
caffeine group = 6.889 ± 1.164). 
CORNER OCCUPANCY 
There was an overall dose effect, F(2,58)= 3.236, p< .05, due to lower 
corner occupancy with the low dose than with the high dose, F(2,34)= 3.518, 
p< .05. Mean scores were 29.457 ± 1.556 for saline, 25.429 ± 1.546 for the low 
dose and 30.743 ± 2.005 for the high dose. 
DEFECATION 
A sex effect, F(l,29)= 34.271, p< .05, was found to be due to males 
defecating more than females, (males= 3.431 ± .48 and females= .389 ± .164). 
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There was a dose effect, F(2,58)= 7.480, p< .005, which was due to 
lowered defecation with the high dose of diazepam (M=.886 ± .352) 
compared with saline (M= 2.286 ± .456) and the low dose (M=2.429 ± .508). 
A sex x dose interaction was found, F(2,58)= 3.887, p< .05, which was 
due to a dose effect for males only, F(2,58)= 10.269, p< .0001. There was lower 
defecation with the high dose of diazepam compared with saline. The mean 
for the saline dose was 3.824 ± .649 and for the high dose, 1.824 ± .66. 
EMERGENCE 
An overall sex effect, F(l,29)=5.412, p< .05, revealed that females had 
shorter emergence latencies than males(113.3 ± 21.905 for females and 189.49 
± 25.568 for males). 
There was a dose effect, F(2,58)= 4.464, p<.02, due to shorter latencies 
to emerge with the low dose ( 125.4 ± 22.853) compared with the high dose 
(185.257 ± 21.444) which had an increased latency. 
REARING 
A dose effect was present, F(2,58)= 40.682, p< .0001. There was lowered 
rearing with the high dose (5.229 ± .78) compared with saline (16.171 ± 
1.216)and the low dose (13.286 ± 1.093). 
STILL 
There was a dose effect, F(2,58)= 25.251, p<.0001. Increased time was 
spent still at the high dose (17.486 ± 1.82) compared with the saline (4.943 ± 
1.183) and the low dose (7.143 ± 1.279). 
WALKING 
A sex difference was found, F(l,29)= 20.390, p< .0001. Females were 
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found to walk more than males (males= 12.686 ± .574, females= 16.259 ± 
.599). 
A dose effect was also found, F(2,58)=12.625, p< .0001, however these 
sex and dose effects interacted, F(2,58)= 4.148, p< .05. This was due to a dose 
effect for females only, F(2,58)= 14.942, p< .0001. There was decreased 
walking with the high dose of diazepam compared with saline and the low 
dose of diazepam (saline = 18.889 ± 1.551, low dose = 19.389 ± 1.669 and the 
high dose= 10.5 ± .72). 
CAFFEINE 
AMBULATION 
A sex effect was found, F(l,29)= 9.598, p< .005. Females had higher 
ambulation(49.481 ± .785) than males(44.118 ± 1.628). 
There was a dose effect, F(2,58)= 31.383, p< .0001. Higher ambulation 
occurred with the low and high dose of caffeine compared with saline 
(saline= 39.8 ± 1.933, low dose= 50.029 ± .734 and high dose= 50.8 ± .905). 
CENTRE 
A dose effect was found, F(2,58)= 27.590, p< .0001. Lower centre 
occupancy was found with the saline dose (5.437 ± .737) than with the low 
(10.429 ± .686) or high dose of caffeine (10.743 ± .496). 
CORNER 
There was a dose effect, F(2,58)= 18.867, p< .0001, which showed that 
with the saline dose, higher corner occupancy occurred than with the low or 
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high dose of caffeine, (saline = 29.457 ± 1.556, low dose = 21.286 ± 1.055 and 
high dose= 21.171 ± .658). 
DEFECATION 
There was a sex effect, F(l,29)= 23.024, p< .0001, males defecated more 
than females (males = 4 ± .53, females = .944 ± 0.304). 
EMERGENCE 
A sex effect was present, F(l,29)= 8.126, p< .01. Males took longer to 
emerge than females, (males = 160.853 ± 18.121 and females = 91.352 ± 
15.051). 
GROOMING 
A perinatal caffeine effect occurred, F(2,29)= 4.458, p< .05. The high 
perinatal caffeine exposed group groomed more than either the controls or 
the low perinatal caffeine group (high group = 2.806 ± .354, control = 1.606 ± 
.254, low group = 1.722 ± .309). 
A sex x acute dose interaction existed, F(2,58)= 3.434, p<.05. Further 
analyses showed that this was partly due to a dose effect for males only, 
F(2,58)= 4.247, p< .05. There was lower grooming with the high dose of 
caffeine (1.294 ± .371) compared with saline (3.176 ± .787). However most of 
this interaction was due to a sex effect for saline treated animals only, 
F(l,86)= 4.236, p< .05, (males= 3.176 ± .787 and females= 1.778 ± .286). 
REARING 
There was a marginally significant perinatal caffeine effect, F(2,29)= 
3.230, p<.06. There was higher rearing by the controls compared with the 
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high perinatal caffeine group and the low perinatal caffeine group (control = 
18.515 ± 1.31, low group = 14.444 ± 1.09 and the high group mean = 14.917 ± 
1.169). 
STILL 
A dose effect, F(2,58)= 3.191, p< .05, was found to be due to animals 
treated with the saline spending more time still than when given the low or 
high dose of caffeine (saline = 4.943 ± 1.183, low dose = 2.543 ± .547 and high 
dose= 2.343 ± .42). 
WALKING 
A sex effect was found, F(l,29)= 15.044, p< .001. Females had higher 
walking than the males (females = 22.815 ± .492, males = 19.157 ± 1.137) 
There were two sets of interactions, sex x dose, F(2,58)= 3.199, p<.05, 
and sex x caffeine, F(2.29)= 12.905, p< .0001. 
The sex x dose interaction was due to a sex effect at the saline dose, 
F(l,82)= 4.596, p< .05, and the high caffeine dose, F(l,82)= 12.695, p< .001, the 
females walked more than the males at the saline dose. At the high dose, 
the males walked more than the females (saline = 14.824 ± 1.29 for males and 
18.889 ± 1.551 for females, at high dose = 22.059 ± 1.648 for males and 10.5 ± 
.72 for females). 
There was a dose effect for males, F(2,58)=7.561, p< .001. Lower 
walking occurred with saline (14.824 ± 1.29) than with the low (22.059 ± 
1.648) or high dose (20.588 ± 1.957). 
A dose effect for females also existed, F(2,58)= 10.187, p< .0001. The 
high caffeine dose (27.722 ± 1.468) resulted in higher walking than saline 
(18.889 ± 1.551). 
The sex x perinatal caffeine interaction was due to a perinatal caffeine 
effect for males but not females, F(2,29)= 17.053, p< .0001. The control group 
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had higher walking than the low perinatal caffeine group, and the high 
perinatal caffeine group. The low perinatal caffeine group also had higher 
walking than the high perinatal caffeine group (control = 23.933 ± 1.762, low 
group = 19.389 ± .611 and the high group mean was 14.944 ± 1.381). 
There was also a sex effect for the low perinatal caffeine group, 
F(l,29)= 4.515, p< .05, and for the high perinatal caffeine group, F(l,29)= 
36.019, p< .0001. Females walked more than males for both (low group = 
22.556 ± 1.17 for females and 19.389 ± .611 for the males, high group = 23.889 
± .556 for females and 14.944 ± 1.381 for the males). 
Figure 1 (a). Effect of diazepam on ambulation by rats 
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FIGURE 1 (b). Effect of caffeine on ambulation by rats 
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Figure 2(a). Effect of diazepam on centre occupancy 
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Figure 2(b). Effect of caffeine on centre occupancy 
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Figure 3(a). Effect of diazepam on corner occupancy 
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Figure 3(b). Effect of caffeine on corner occupancy 
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Figure 4(a). Effect of diazepam on defecation by 
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Figure 4(b). Effect of caffeine on defecation by 
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Figure 5(a). Effect of diazepam on emergence latency 
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Figure 5(b). Effect of caffeine on emergence latencies 
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Figure 6(a). Effect of diazepam on grooming by 
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Figure 6(b). Effect of caffeine on grooming by 
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Figure 7(a). Effect of diazepam on rearing in 
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Figure 7(b). Effect of caffeine on rearing by rats 
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Figure 8(a). Effect of diazepam on still behaviour 
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Figure 9(a). Effect of diazepam on walking by rats 
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Figure 9(b). Effect of caffeine on walking 
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Effects on behavioural measures, with administration of saline, CHA 
and oxprenolol at low and high doses after exposure to perinatal caffeine,for 




Sex effects were found, F(l,29)= 13.062, p< .002. Females had higher 
ambulation scores than males (36.608 ± 1.196 for females, 21.093 ± 1.419 for 
males. 
A dose effect occurred, F(2,58)= 36.630, p< .0001. There was higher 
ambulation with the saline dose (39.086 ± 1.707) than the low (27.543 ± 2.261) 
or high dose (19.257 ± 2.047), and there was also higher ambulation with the 
low dose than with the high dose of chlorohexyladenosine. 
CENTRE OCCUPANCY 
A dose x perinatal caffeine interaction occurred, F(4,58)= 3.061,p< .05. 
This was accounted for by a dose effect for the high perinatal caffeine group, 
F(2,58)= 6.178, p< .005. There was more centre occupancy by the high caffeine 
group at the high dose than at the low dose, 11.545 ± 3.399(high dose) and 
4.091 ± .857(1ow dose). 
DEFECATION 
An overall sex effect, F(l,29)= 17.556, p< .0005, showed that males 
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have higher defecation than females (2.648 ± .283 for males and 1 ± .241 for 
females). 
A further sex x dose interaction revealed that there was a dose effect 
for males only, F(2,58)= 17.223, p< .0001. Decreased defecation was found 
with both the low and high dose of CHA, (1.667 ± .548 for the low dose and 
1.333 ± .404 for the high dose). 
EMERGENCE 
Males took longer to emerge than females, F(l,29)= 14.156, p< .001, 
(289.519 ± 7.193 for males, 193.078 ± 26.511 for females). 
GROOMING 
A sex effect, F(l,29)= 3.926, p< .06, revealed that males were found to 
groom more than females overall, (males = 3.889 ± .778, females = 2.137 ± 
.308). 
There was a perinatal caffeine x dose interaction found, F(4,58)= 3.811, 
p< .01. This occurred because of a dose effect for the high perinatal caffeine 
group, F(2,58)= 3.897, p< .05. There was lower grooming by this group with 
the high dose of CHA (saline = 4.727 ± 1.01, low dose = 2.364 ± 1.089, high 
dose= 1.091 ± .476). 
REARING 
There was a sex effect, F(l,29)= 16.325, p< .0005, females reared more 
than males (females = 9.078 ± .837, males = 5.148 ± .602). 
A dose effect, F(2,58)= 43.039, p< .0001, revealed that more rearing 
occurred with the saline dose than with either the low or high dose. The low 
dose gave greater rearing than the high dose (saline = 11.6 ± .908, low dose = 
6.686 ±.892, high dose = 2.886 ± .584). 
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STILL 
A sex effect was found, F(l,29) = 31.236, p< .0001, males spent more 
time still than females (males = 18.167 ± 2.089, females = 5.333 ± .828). 
A dose effect, F(2,58) = 32.390, p< .0001, revealed that more time was 
spent still with the low and high dose than with the saline and more time 
was spent still with the high dose than with the low dose, (saline= 3.4 ± .764, 
low dose= 11.914 ± 2.2, high dose= 20.486 ± 2.75). 
A sex effect at low and high dose showed that males spent more time 
still at the low dose, F(l,80) = 19.188, p< .0001 and at the high dose, F(l,80) = 
39.579, p< .0001. Means for the low dose = 19.056 ± 3.444 for males, 4.353 ± 
.939 for females, high dose = 30.611 ± 3.667 for males and 9.765 ± 1.975 for 
females. 
WALKING 
Females showed more walking than males, F(l,29) = 96.803, p< .0001, 
(females= 14.745 ± .495, males= 7.981 ± .497). 
A dose effect, F(2,58) = 18.788, p< .0001, showed that there was more 
walking with the saline than with the low or high dose of CHA (saline = 
14.771 ± .947, low dose= 10.886 ± 1.009, high dose= 8.143 ± .807). 
OXPRENOLOL 
AMBULATION 
A sex effect was found, F(l,28) = 36.425, p< .0001. Females had higher 
ambulation scores than males, (males= 34.185 ± 1.444, females= 44.49 ± .967. 
There was a dose effect, F(2,56) = 4.160, p< .05. The low dose resulted 
in higher ambulation than the high dose, (low dose = 41.853 ±1.239, high 
dose = 36.294 ± 1.767. 
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A sex x perinatal caffeine interaction occurred, F(2,28) = 2.949, p< .07. 
This was due to a sex effect for the controls, (males= 36.278 ± 2.114, females = 
44.889 ± 2.167) , the low perinatal caffeine group (males = 36.333 ± 2.434, 
females = 42.833 ± 1.556) and the high perinatal caffeine group, (males = 
29.944 ± 2.34, females = 46 ± .775). Males had lower ambulation in all three 
groups. 
CENTRE 
Females had higher centre occupancy than males, F(l,28) = 3.738, p< 
.05 (females= 6.039 ± .565, males= 4.815 ± .578. 
There was a sex x perinatal caffeine interaction, F(2,28) = 4.470, p< .05. 
This was due to a caffeine effect for females only, F(2,28) = 5.327, p< .05. The 
high perinatal caffeine group spent more time in the centre than the 
controls or the low perinatal caffeine group. The mean for controls = 4.944 ± 
.617, low group= 5.056 ± .691, high group= 8.533 ± .923. 
DEFECATION 
There was a sex effect, F(l,28) = 49.337, p< .0001. Males were found to 
defecate more than females, (males = 3.204 ± .267, females = .863 ± .28. 
A dose effect, F(2,56) = 13.659, p< .0001, showed that there was higher 
defecation with the saline dose than with the low or high dose of 
oxprenolol, (saline dose = 3.471 ± .486, low dose = 1.706 ± .399, high dose = 
.941 ± .242). 
A sex x perinatal caffeine effect, F(2,28) = 3.449, p< .05, indicated that 
there was a caffeine effect for the males only, F(2,28) = 3.410, p< .05. The low 
perinatal caffeine group defecated less than the controls (low group = 2.556 ± 
.294, control group= 4.056 ± .467). 
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EMERGENCE 
There was a sex effect, F(l,28) = 22.719, p< .0001. Males took longer to 
emerge than females, (males = 279.907 ± 10.848, females = 147.922 ± 27.336). 
GROOMING 
A sex effect, F(l,28) = 19.174, p< .0005, showed that males groomed 
more often than females, (males = 3.833 ± .415, females = 1.725 ± .404). 
REARING 
There was a sex effect, F(l,28) = 16.642, p< .0005. Females reared more 
than males, (females= 13.784 ± .908, males = 9.981 ± .685). 
A marginal caffeine effect was found, F(2,28) = 2.905, p< .075. The low 
perinatal caffeine group had lower rearing than the control group. The 
mean for the low group= 10.694 ± .717 and the control group= 13.694 ± 1.1). 
STILL 
There was a sex effect, F(l,28) = 6.978, p< .02. Males spent more time 
still than females, (males= 3.13 ± .742, females= 1.02 ± .222). 
A dose effect, F(2,56) = 6.464, p< .005, showed that more time is spent 
still with the saline dose than with the low dose (saline = 3.441 ± .786, low 
dose= .853 ± .261). 
WALKING 
Females walked more than males, F(l,28) = 20.840, p< .0001 (females = 
17.784 ± .788, males= 12.833 ± .606). 
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EMERGENCE 
There was a sex effect, F(l,28) = 22.719, p< .0001. Males took longer to 
emerge than females, (males = 279.907 ± 10.848, females = 147.922 ± 27.336). 
GROOMING 
A sex effect, F(l,28) = 19.174, p< .0005, showed that males groomed 
more often than females, (males = 3.833 ± .415, females = 1.725 ± .404). 
REARING 
There was a sex effect, F(l,28) = 16.642, p< .0005. Females reared more 
than males, (females= 13.784 ± .908, males = 9.981 ± .685). 
A marginal caffeine effect was found, F(2,28) = 2.905, p< .075. The low 
perinatal caffeine group had lower rearing than the control group. The 
mean for the low group= 10.694 ± .717 and the control group= 13.694 ± 1.1). 
STILL 
There was a sex effect, F(l,28) = 6.978, p< .02. Males spent more time 
still than females, (males= 3.13 ± .742, females= 1.02 ± .222). 
A dose effect, F(2,56) = 6.464, p< .005, showed that more time is spent 
still with the saline dose than with the low dose (saline = 3.441 ± .786, low 
dose= .853 ± .261). 
WALKING 
Females walked more than males, F(l,28) = 20.840, p< .0001 (females = 






































Figure 1 O(a). Effect of CHA on ambulation by 
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Figure 1 O(b). Effect of oxprenolol on ambulation 
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Figure 11 (a). Effect of CHA on centre occupancy 
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Figure 11 (b). Effect of oxprenolol on centre occupancy 
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Figure 12(a). Effect of CHA on corner occupancy 
















Control Low High 
Perinatal Caffeine Group 
Figure 12(b). Effect of oxprenolol on corner occupancy 
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Figure 13(a). Effect of CHA on defecation by 
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Figure 13(b). Effect of oxprenolol on defecation by 
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Figure 14(a). Effect of CHA on emergence latencies 
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Figure 14(b). Effect of oxprenolol on emergence latencies 
by rats perinatally exposed to caffeine 
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Figure 15(a). Effect of CHA on grooming in rats 
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Figure 15(b). Effect of oxprenolol on grooming by 
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Figure 16(a}. Effect of CHA on rearing by 
rats perinatally treated with caffeine 
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Figure 16(b}. Effect of oxprenolol on rearing by 
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Figure 17(a). Effects of CHA on still behaviour 
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Figure 17(b). Effect of oxprenolol on still behaviour 
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Figure 18(a). Effect of CHA on walking by 
rats exposed perinatally to caffeine 
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Figure 18(b). Effect of oxprenolol on walking by 
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Many significant effects and trends emerged in this study. These will 
be considered in this discussion which comprises five parts. The first part 
examines the significant results to emerge in the first experiment and the 
differences between diazepam and caffeine on rat behaviour. The second 
part discusses CHA and oxprenolol's effects. Then some general findings 
overall will be examined. The third part will entail considering other 
factors which may be involved while the fourth part is a consideration of 
the brain mechanisms influencing behaviour. The last section will discuss 
general findings and some suggestions for future research will be made. 
EXPERIMENT ONE 
Diazepam and the acute caffeine doses resulted in different 
behavioural responses. Caffeine gave a largely stimulant effect for the 
measures showing activity: ambulation, time spent still and walking. 
Diazepam however showed decreased activity for measures of ambulation, 
rearing, still and walking. 
Dose effects occurred with diazepam for the high dose only, whereas 
with acute caffeine treatment, dose effects occurred for both the low and 
high doses. This indicates the sedatory effect of diazepam at the higher dose. 
Sedation effects are known to occur with diazepam as part of the anti-
anxiety effect (Wu and Coffin, 1984). Regarding the other measures, 
defecation was lowered at the high dose of diazepam in males whereas no 
such effect was found for caffeine. An increased latency to emerge was 
found with the high dose of diazepam while again, rats were not affected by 
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doses of caffeine. Lowered grooming was found with the caffeine at high 
dose. Higher centre occupancy and lower corner occupancy occurred at lm-v 
and high doses of caffeine while diazepam decreased centre occupancy at 
high dose and decreased corner occupancy at the low dose. 
These results can best be described in terms of stimulation by caffeine 
and locomotor depression by diazepam. Examining the effects of caffeine 
first, the direct activity measures showed increased activity. However, the 
decreased grooming and decreased corner and centre occupancy may also be 
due to this stimulation by caffeine since moving around more means that 
the animals are not staying in one place such as the corners or the centre of 
the apparatus. They would not be on one spot to groom either. 
Perinatal caffeine effects are of great interest, and they occurred for 
several of the measures when caffeine was administered. Grooming was 
higher in the high perinatal caffeine group and rearing and walking were 
lower in the low and high perinatal caffeine groups. There was also a trend 
although not significant, for male defecation to be higher in the high 
perinatal caffeine group while female defecation tended towards being 
higher in the low perinatal caffeine group (see figure 4(b)). 
A possibility for this difference is that rats previously exposed to 
caffeine perinatally may have developed a longlasting tolerance to 
caffeine's effects. Tolerance is known to develop to caffeine with chronic 
exposure and Lombardelli et al. (1984) have provided evidence for longterm 
tolerance after caffeine exposure has finished. Activity by the control rats 
was increased compared with the experimental rats. However this may not 
be the case with this experiment since the prenatally exposed rats given 
saline also showed lowered activity compared to control rats given saline, 
while experimental group rats in the Lombardelli et al. study had slightly 
higher activity than controls with saline treatment. 
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The difference may instead be a sign of higher emotionality and 
depressed activity which is found at higher levels of caffeine intake. The 
biphasic effect of caffeine found at different doses did not show up in this 
experiment. The lack of biphasic effects from the acute caffeine was not 
unexpected considering that the doses used were fairly low and within the 
stimulant dose range. The lack of a difference between the low and high 
perinatal caffeine groups, which has been found in past research by Hughes 
and Beveridge (1990), may be due to one of several reasons. There may not 
be any difference between the two groups this long after exposure and the 
age of the animals or the test procedure may be resulting in different 
behaviour. These possibilities will be discussed again in the section about 
factors influencing the study. 
Diazepam doses led to many depressant effects but only at the high 
doses. Low doses gave behaviour which was similar to saline. Corner 
occupancy increased with the high dose of diazepam which may be due to 
decreased activity. Rats seem to stay in the corners more when they are not 
moving around much. The increased latency to emerge was also consistent 
.. ~ith lowered activity and sedation. Lowered defecation may have reflected 
lowered fear with greater sedation. 
One perinatal caffeine effect occurred for centre occupancy, namely 
the low and high perinatal caffeine exposed groups spent more time in the 
centre. This could have been due to lowered fear. 
EXPERIMENT TWO 
While dose effects with CHA were evident, those for oxprenolol were 
few. CHA had a largely sedatory effect which is consistent with the reported 
effects of adenosine analogs (Dunwiddie,1985). The lower dose showed a 
lesser degree of sedation than the high dose. Oxprenolol did not have any 
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visible effects on the rats. It certainly did not sedate, which is an advantage 
of beta blocker use over other anxiolytic agents (Noyes, 1982). 
Ambulation was reduced by the low and high dose of CHA but was 
higher with the low dose of oxprenolol than the high dose . Rearing and 
walking were lowered by CHA while oxprenolol had no effect on these 
responses. Defecation was lowered with both doses of both drugs. 
However, the dose effects interacted with perinatal caffeine effects for centre 
occupancy and grooming with CHA. 
The results for oxprenolol are few but those that did occur suggest 
more of a stimulating role than a sedating one. Beta blockers are known to 
have effects on the peripheral symptoms of anxiety whereas the effect on 
the central nervous system is a matter of debate (Noyes, 1982). This 
experiment did not allow a distinction to be made between these two 
mechanisms to discover which is responsible for oxprenolol's actions. 
However the lack of results may suggest that the CNS is not being affected. 
If oxprenolol is reducing the somatic symptoms of fear then the rats may 
become more active in the way found, due to a relaxation of fear symptoms. 
Several perinatal caffeine effects were found in rats treated with 
oxprenolol. Centre occupancy was higher for females in the high perinatal 
caffeine group, males in the low perinatal caffeine group defecated less and 
rearing was decreased for both sexes in the low perinatal caffeine group. All 
these effects suggest a decrease in fear for the low and high perinatal caffeine 
groups after oxprenolol administration. Although perinatal caffeine effects 
were found, the usefulness of beta blockers in animal research has been 
questioned, with suggestions that they do not affect animals. However, 
other researchers have found effects with beta blockers (Hughes, 1981). 
Nevertheless, this could explain the lack of results with this drug or it may 
have been that dose levels were too low to show many effects. 
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CHA affected the rats in a sedative way. Lowered locomotor activity 
was typical in rats, but it is interesting that CHA was the only drug for which 
an interaction between dose and perinatal caffeine occurred. This happened 
for centre occupancy and for grooming. 
Rats in the high perinatal caffeine group spent more time in the 
centre of the open field with the high dose than with the low dose of CHA. 
Grooming was lowered in the high perinatal caffeine group with the high 
dose of CHA. These two measures are possible indices of fear and the rats 
behaviour in both these instances indicates lowered fear. Caution must be 
taken with the grooming measure however since the numbers of grooming 
responses were small therefore making the results less behaviourally 
significant. 
Both measures were affected in the high perinatal caffeine group, 
giving added support for a greater effect of CHA on perinatally caffeine 
treated rats than other drug treatments. It may be that CHA is interacting in 
the adenosine system in the brain in some way to affect the behaviour more 
than other drug treatments. The other two anti-anxiety agents also 
increased centre occupancy for the high perinatal caffeine groups which was 
an interesting finding. They may have decreased fear as well, but it may be 
that CHA had a greater effect evidenced by the dose interacting with the 
perinatal caffeine effect. 
BRAIN MECHANISMS 
The implications of these results for the effect on the brain by 
perinatal caffeine are minimal. The effects of all the drugs on behaviour, 
particularly on emotionality were small. Evidence of increased 
emotionality in the perinatal caffeine exposed groups was hard to find. In 
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particular, defecation, usually described as the best measure for fear, was not 
greatly affected. Diazepam-, CHA- and oxprenolol-treated rats did show a 
decrease in defecation with low and high doses of CHA and oxprenolol and 
with the high dose of diazepam. Although sedation may account for this to 
some extent, the decrease with oxprenolol, for which there was a perinatal 
caffeine effect, suggests that an anti-anxiety effect may be responsible as well. 
Emergence was another disappointing measure. This failed to show 
any results other than sex differences. The one dose effect, which occurred 
for diazepam, was most probably due to sedation. This lack of results may 
be due to the testing procedure which will be mentioned in the next section. 
Grooming was increased with acute caffeine in the high group more 
than the other two treatments which may indicate increased fear. When rats 
in the high perinatal caffeine group were given CHA, lower grooming was 
found at the high dose, perhaps showing a greater effect of CHA on these 
rats than the other groups. The amount of grooming actually recorded in 
these experiments was very low. As it was a fairly rare behaviour, this data 
may not give a very good indication of the effects of the drugs. 
Centre and corner occupancy gave very interesting results. These 
measures are not considered to be very reliable indices of emotionality 
(Archer, 1973) but with diazepam, CHA and oxprenolol more centre 
occupancy did occur in the high perinatal caffeine group than in either of 
the other two groups. This is hard to explain but it is tempting to relate it to 
reduced emotionality especially since the acute caffeine doses did not show 
this effect. Also, the interaction of dose with the perinatal caffeine effect 
with CHA might suggest a greater influence of this drug on caffeine's effects. 
If CHA can influence the behavioural effects of perinatal caffeine 
exposure, this gives support for the proposal that adenosine is being altered 
in the rat brain. The way in which this occurs is not fully known. Many 
researchers have found increased numbers of adenosine receptors with 
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caffeine exposure (Boulenger et al., 1983). As diazepam did not have much 
effect on the rats, it is unlikely that the benzodiazepine was affecting the 
adenosine receptor. 
Increased receptors may not mean that increased extracellular 
adenosine is responsible for the anxiogenic effects found with caffeine. If 
this were so, the adenosine agonists would not be proposed as anxiolytic in 
action. This is a difficulty for the adenosine theory. Adenosine should not 
be expected to increase anxiety when it is known that it has sedative, 
relaxant properties. Perhaps this discrepancy can be resolved with better 
knowledge of the different receptors or it may be that adenosine is 
influencing other neurotransmitters, which are causing the effects. It seems 
more and more likely that not one brain system or neurotransmitter is 
involved in caffeine's effects but many are interacting to produce the effects. 
It has also been suggested that adenosine may be responsible for the decrease 
in activity while the anxiety effects may be mediated elsewhere. But it is 
also likely that the depressed activity found with the increased emotionality 
is secondary, that is, it may actually be a result of increased anxiety. 
FACTORS INFLUENCING THE STUDY AND CRITICISMS 
SEX EFFECTS 
Worthy of mention is the great number of sex effects which revealed 
themselves in the experiments. These were not unexpected, since many 
investigators have reported similar sex differences in behavioural studies 
(Hughes and Beveridge,1986, 1990). Males are bigger and heavier than 
females are therefore usually found to be much slower. Males also defecate 
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a lot more than females which was found for every instance of the 
defecation measure. The emergence measure also revealed a longer latency 
to emerge by male rats on every occasion, most likely due to the lower 
activity of the males. 
Males have also been reported to be more affected by some drugs than 
females are. Hughes and Beveridge (1991) found that males were more 
susceptible to caffeine effects when exposed either prenatally or postnatally 
alone and the effects generalized over to females as well only when caffeine 
was given during both periods. 
This study also found some support for this male-only effect. The sex 
and perinatal or dose interactions involved female effects only in three out 
of ten interactions while five out of ten involved male-only effects. 
Al though this is not overwhelming evidence for male only-effects, the rats 
tested in Hughes and Beveridge (1990) study were the only group exposed 
perinatally, when both sexes were affected by caffeine. 
This sex difference may be due to a sex hormone or some other sex 
dependent trait. Holloway and Thor (1984) have provided some evidence 
for testosterone being involved. When testosterone was high, an increase 
in social investigation occurred with caffeine administration. This effect 
was with acute caffeine treatment so perhaps different situations might 
characterise chronic treatment and testosterone effects. 
Gray (1982) gives a cautionary message in regard to sex differences. It 
may be the case that in rats, males show greater fear responses than females, 
but in humans this effect shows the opposite pattern with females being the 
most prone to fear and anxiety. However it is difficult to recognise purely 
biological effects in humans, with cultural patterns so influential. 
Nevertheless, it is important to remember that the rat effects may not be 
appropriate for extrapolation to the human situation. 
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PROBLEMS IN THE RESEARCH 
A problem with comparing this research with the human situation 
is the issue of brain development in both species. Caffeine was exposed to 
rats perinatally to mimic the situation in humans with mothers ingesting 
caffeine during pregnancy and when breast-feeding. This seems the most 
likely pattern of behaviour in caffeine consumption by mothers. However, 
gestation and lactation are not equivalent in rats and humans. The 
developmental stages of the brain differ with the rats brain continuing to 
develop for relatively longer after birth. The equivalent of gestation and 
lactation in the rat for humans may be gestation alone. Therefore the data 
on perinatal effects in rats may be more suitable for showing the possible 
effects with caffeine exposure during gestation alone in humans. 
Hughes and Beveridge (1991) covered the possible influence of 
environmental factors on offspring by altered behaviour in mothers 
ingesting caffeine, by fostering the young. Another similar problem 
however concerns effects on the prenatal environment, apart from the 
caffeine reaching the fetus. There is the possibility that the mothers' altered 
behaviour by caffeine ingestion may have influenced their unborn offspring 
(Archer and Blackman, 1971). 
Boulenger et al. (1986) found that prenatal stress as well as caffeine, 
alters adenosine receptors. Pohorecky et al. (1989) found prenatal stress 
affected behaviour and altered sensitivity to caffeine in regard to corner 
activity and rearing and it decreased gnawing activity. Therefore it is 
possible that the dams' behaviour may be affected by caffeine. West et al. 
(1986) found dams behaviour after caffeine exposure was changed in the 
form of increased activity, decreased weight gain and a lowered food intake. 
If greater stress is experienced by the dams, the chemical and 
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neuroendocrine changes may be reaching and affecting the offspring. The 
knowledge that caffeine by itself does cause anxiety however makes it 
unlikely that prenatal stress alone is causing the changes in offspring 
behaviour, but they may have an additive effect. Controlling for this 
prenatal stress would be virtually impossible to do. 
The amount of caffeine given to the rats has been a matter of debate 
as well. The doses given are extraordinarily high compared to the amount 
of caffeine consumed by people, Hughes and Beveridge (1990) estimated that 
a 28 mg/kg/ day dose of caffeine is equivalent to about 16 cups of coffee in a 
56 kg woman. This is very high, but if metabolic differences and surface 
area are taken into account the equivalent amount in the same 56 kg 
woman is about five and a half cups of coffee, which is far closer to the real 
situation. 
The design of the experiments may have been responsible for some 
lack of effects. The main problem in the design was the use of a repeated 
measure procedure. Although an attempt was made to guard against the 
repeated testing of rats influencing their behaviour (by testing each rat a 
week after its previous test), it seems as if this may have happened. Archer 
(1973) reported many examples of repeated testing causing an adaptation 
effect. These were usually studies that tested the rats every day, the testing 
arena became a familiar place which changed the behaviour. 
The number of rats used in this study made it difficult to assess the 
possibility of adaptation by the rats, especially with the method employed of 
testing all rats in one cage in succession. However the emergence data did 
seem to confirm that the repeated measure was obscuring results. A each 
rat had more exposures to the emergence apparatus, it became more likely 
that they would emerge. Very few emerged on the first trial but most had by 
their fifth trial. In the second experiment rats were not tested as often as in 
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the first, more rats failed to emerge in the second experiment overall, 
reflecting the longer periods away from (and possibly lower familiarity with) 
the apparatus (compare figure 14 with figure 5). If familiarity has occurred 
then it seems inevitable that it would influence behaviour. In spite of such 
influences, it is clear that some effects still occurred suggesting that they 
were fairly robust. 
Fear from the testing procedure itself is likely to have occurred. It has 
been shown that bright light and noise are fearful stimuli in the open field 
for rats (Walsh and Cummins, 1976, Archer, 1973) although a relationship 
between bright light and defecation does not seem to exist (which seems 
unusual since defecation is regarded as the major fear index). White noise 
has been shown to decrease locomotion but it has also been reported to 
increase locomotion and defecation at levels over 90 dB. 
White noise of 58 dB and the fluorescent tube light were employed in 
this study to control extraneous variables. The light kept a constant amount 
of illumination over the entire open field area and the white noise was 
needed to mask background noise. All rats were exposed to an equal 
amount of white noise and light. 
An attempt was also made to exclude fear of the experimenter. Rats 
were handled daily for several weeks before the commencement of the 
experiment. However, the injection of the rats may have caused some fear 
reactions, particularly since five injections in total were given to each rat 
and an association of the injection with the experimenter may have 
developed. Testing each rat in succession from each cage may have caused 
more fear in the rats, injected rats may have influenced those to be injected 
or all injected rats may have developed the same emotional state. 
Age of the rats is also a matter of interest. These rats were tested at 8 
to 11 months after birth. Decreases in activity and greater emotionality 
8"1 
have often been found as age increases (Hughes and Beveridge, 1986). 
However, Hughes and Beveridge (1990) found age-related increases in 
ambulation and rearing but decreased walking. It is difficult to see effects of 
age in these experiments as sedation was so marked. Perhaps sedation was 
greater due to the age of the animals. 
The measures used in this study are the final problem that will be 
mentioned. What is actually being measured is a matter of concern. 
Emotionality is very difficult to assess in animals particularly when defined 
as "anxiety". Fear in rats may be possible to measure but is still subjective. 
The behavioural measures were more likely to measure fear which was 
possibly similar to anxiety in humans. Therefore the terms are often used 
interchangeably. 
The emotionality or fear measures used in this study were defecation 
(the most valid index), corner or centre occupancy, emergence from a dark 
box to an illuminated area and grooming, which is probably the weakest 
measure involving a type of displacement behaviour when fearful. 
However it may just be a behaviour which is performed when the rat is not 
doing anything else. 
The activity measures while also relating to the fear measures, are 
often described as exploratory or escape behaviours. Ambulation, walking 
and rearing have all been treated as exploratory measures when they may 
not be (Archer, 1973). Escape behaviour might be best measured by fast 
ambulation when a rat is first placed in the open field, or rearing against the 
sides of the open field may be an escape behaviour. It is difficult to 
distinguish between escape and exploratory behaviours but with this 
distinction existing it may be that different behavioural measures are 
controlled in different brain areas. 
The relatedness of the measures are of interest with this point in 
mind. All three measures (as well as time spent still showing the inverse 
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relationship), show a similar pattern of effects. There was a decrease in 
activity with diazepam and CHA administration. Ambulation was 
increased with oxprenolol at the low dose, less time was spent still with the 
low dose while no dose effect occurred for rearing or walking. Higher 
rearing was found in the control group, the low group had decreased 
rearing. 
Caffeine also gave mixed results. Higher walking and higher 
ambulation occurred at low and high dose, less time was spent still but 
again no dose effect was found for the rearing measure. But lower rearing 
and lower walking occurred for the two perinatal caffeine groups. Rearing 
may be separate from the other measures but it did relate to walking in the 
perinatal caffeine effects. Therefore this experiment was not rigorous 
enough to distinguish any differences in the activity measures, although 
Hughes and Beveridge (1991) have suggested that a difference between 
walking and ambulation that they found may reflect different underlying 
mechanisms. In this type of study it may be better to merely consider these 
measures as activity measures and not consider exploration and escape 
functions. 
GENERAL CONCLUSIONS AND FUTURE RESEARCH 
The most interesting results occurred for the measure of centre 
occupancy, particularly with CHA administration. Dose interacted with 
perinatal caffeine group showing a significantly greater amount of time 
spent in the centre of the open field than in the periphery of the arena, for 
the high perinatally exposed group given the high dose of CHA. Higher 
centre occupancy also occurred in the high perinatal caffeine groups with 
diazepam and oxprenolol administration but this was not dose specific. 
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This leads to a tentative suggestion that they are all reducing anxiety in the 
high perinatal caffeine groups but that in the CHA treatment the effect is 
more pronounced, suggesting a greater influence of this drug on rats 
behaviour. This could be due to the adenosine system in the brain being 
more affected in rats exposed to the high dose of caffeine throughout 
gestation and lactation. 
Reduced activity was evident with diazepam at the high dose only 
and with CHA at both the high and low dose, the low dose being 
intermediary between saline and the high dose. This was due to the 
sedative action of both drugs. Oxprenolol stimulated activity which may be 
due to somatic fear symptoms being relieved. Caffeine had a largely 
stimulating effect except for the finding of reduced activity by males in the 
low and high perinatal caffeine groups for the measure of walking. Higher 
grooming and rearing was found in the high perinatal group which is 
suggestive of increased emotionality/ fear. 
This study was fairly limited in that the brain mechanisms involved 
were not immediately accessible. A further study of a wide range of 
behavioural effects from perinatal caffeine exposure needs to be made with 
an examination of brain slices to find changes in the brain adenosine 
receptors and of other possible receptors involved. Levels of 
neurotransmitters such as NE and seratonin should be measured to find 
out if they are being altered. This may be related to receptor numbers in the 
brain. It may be that increases in adenosine are influencing, most probably 
inhibiting, neurotransmitter systems so these levels may correlate. There is 
a lack of studies measuring behavioural changes in the brain after perinatal 
caffeine exposure relating this to the brain abnormalities or differences 
which have been found. Both aspects need to be examined in the same rats. 
The implications of upregulated adenosine receptors are not clear. 
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Upregulation does not seem to increase the amount of adenosine in the 
brain or the effect would be a decrease in anxiety. This obviously needs to be 
further examined. When more is understood about adenosine, the problem 
of perinatal caffeine and behavioural effects may be better understood. 
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